QLS1410

DRUG2 trials

Sponsors

Qilu Pharmaceutical Co., Ltd.

Conditions

Primary AldosteronismUncontrolled Hypertension

Phase 1

A Food Effect Study of QLS1410 in Healthy Chinese Adults

Not yet recruitingNCT07358858

Qilu Pharmaceutical Co., Ltd.Uncontrolled Hypertension

Start: 2026-01-23End: 2026-02-07Target: 12Updated: 2026-01-22

Phase 2

Study of QLS1410 in the Treatment of Primary Aldosteronism.

Not yet recruitingNCT07550465

Qilu Pharmaceutical Co., Ltd.Primary Aldosteronism

Start: 2026-06-01End: 2027-04-01Target: 60Updated: 2026-04-24